Abstract
A fermentation method that bypasses the low-yielding semisynthesis of epirubicin (4′-epidoxorubicin) and 4′-epidaunorubicin, important cancer chemotherapy drugs, has been developed for Streptomyces peucetius. This bacterium normally produces the anthracycline antibiotics, doxorubicin and daunorubicin; the 4′-epimeric anthracyclines are formed by introducing the heterologous Streptomyces avermitilis avrE or Saccharopolyspora eryBIV genes into an S. peucetius dnmV mutant blocked in the biosynthesis of daunosamine, the deoxysugar component of these antibiotics. Product yields were enhanced considerably by replacing the chromosomal copy of dnmV with avrE and by introducing further mutations that can increase daunorubicin and doxorubicin yields in the wild-type strain. This method demonstrates that valuable hybrid antibiotics can be made by combinatorial biosynthesis with bacterial deoxysugar biosynthesis genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Service, R.F. 1995. Antibiotics that resist resistance. Science 270: 724–727.
McAlpine, J.B., Tuan, J.S., Brown, D.P., Grebner, K.D., Whittern, D.N., Buko, A., and Katz, L. 1987. New antibiotics from genetically engineerd actinomycetes. I. 2-Norerythromycins, isolation and structural determination. J. Antibiotics 40: 1115–1122.
Weber, J.M., Leung, J.O., Swanson, S.J., Idler, K.B. and McAlpine, J.B. 1991. An erythromycin derivative produced by targeted gene disruption in Saccharopolyspora erythraea. Science 252: 114–117.
Donadio, S., McAlpine, J.B., Sheldon, P.J., Jackson, M., and Katz, L. 1993. An erythromycin analog produced by reprogramming of polyketide synthesis. Proc.Natl. Acad. Sci. USA 90: 7119–7123.
Jacobsen, J.R., Hutchinson, C.R., Cane, D.E. and Khosla, C. 1997. Precursor directed biosynthesis of novel erythromycin analogs by an engineered polyketide synthase. Science 277: 367–369.
Stachless, T., Schneider, A. and Marahiel, M.A. 1995. Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains. Science 269: 69–72.
Epp, J., Huber, M.L.B., Turner, J.R., Goodson, T. and Schoner, B.E. 1989. Production of a hybrid macrolide antibiotics in Streptomyces ambofaciens and Streptomyces lividans by introduction of a cloned carbomycin biosynthetic gene from Streptomyces thermotolerans. Gene 85: 293–301.
Hara, O. and Hutchinson, C.R. 1992. A macrolide 3-O-acyltransferase gene from the midecamycin-producing species of Streptomyces mycarofaciens. J. Bacteriol. 174: 5141–5144.
Arisawa, A., Kawamura, N. Takeda, K., Tsunekawa, H., Okamura, K., and Okamoto, R. 1994. Cloning of the macrolide antibiosynthesis gene acyA which encodes 3-O-acyltransferase, from Streptomyces thermotolerans and its use for direct fermentative production of a hybrid macrolide antibiotic. Appl. Environ. Microbiol. 60: 2657–2660.
Hutchinson, C.R. and Ikeda, I. 1995. Polyketide synthase gene manipulation: A structure-function approach in engineering novel antibiotics. Annu. Rev. Microbiol. 49: 201–238.
Hutchinson, C.R. 1997. Antibiotics from genetically engineered microorganisms, pp. 683–702 in Biotechnology of industrial antibiotics. 2nd ed. Strohl, W.R. (ed.). Marcel Dekker, New York.
Khosla, C. and Zawada, R.J.X. 1996. Generation of polyketide libraries via combinatorial biosynthesis. Trends Biotech. 14: 335–341.
Arcamone, F., Penco, S., Vigevani, A., Redaelli, S., Franchi, G., Di Marco, A., et al. 1975. Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. J. Med. Chem. 18: 703–707.
Weiss, R.B. 1992. The anthracyclines: Will we ever find a better doxorubicin?. Semin. Oncol. 19: 670–686.
Suarato, A., Penco, S., and Arcamone, F. 1982. Process for the preparation of 4′-epidaunorubicin, 3′,4′-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process. US Pat. 4,345,068.
Madduri, K. and Hutchinson, C.R. 1995. Functional characterization and transcriptional analysis of the dnrR, locus that controls daunorubicin biosynthesis in Streptomyces peucetius. J. Bacteriol. 177: 1208–1215.
Otten, S.L., Liu, X., Ferguson, J. and Hutchinson, C.R. 1995. Cloning and characterization of the Streptomyces peucetius dnrQS genes encoding a daunosamine biosynthesis enzyme and a glycosyl transferase involved in daunorubicin biosynthesis. J. Bacteriol. 177: 6688–6692.
Scotti, C. and Hutchinson, C.R. 1996. Enhanced antibiotic production by manipulation of the Streptomyces peucetius dnrH and dnrT genes involved in doxorubicin (adriamycin) biosynthesis. J. Bacteriol. 178: 7316–7321.
Otten, S.L., Gallo, M.A., Madduri, K., Liu, X., and Hutchinson, C.R. 1997. Cloning and characterization of the Streptomyces peucetius dnmZUV genes encoding three enzymes required for the biosynthesis of the daunorubicin precursor, thymi-dine diphospho-L-daunosamine. J. Bacteriol. 179: 7316–7321.
Gallo, M.A., Ward, J. and Hutchinson, C.R. 1995. The dnrM gene in Streptomyces peucetius contains a naturally-occuring frameshift mutation that is suppressed by another locus outside of the daunorubicin-production gene cluster. Microbiology 142: 269–275.
Liu, H.-W. and Thorson, J.S. 1994. Pathways and mechanisms in the biogenesis of novel deoxysugars by bacteria. Annu. Rev. Microbiol. 48: 223–256.
Katz, L. and Donadio, S. 1995. Macrolides. pp. 385–420 in Genetics and biochemistry of antibiotic production. Vining, L.C. and Stuttard, C. (eds.). Butterworth-Heinemann, Boston.
MacNeil, D.J. 1995. Avermectins. pp. 421–442 in Genetics and biochemistry of antibiotic production. Vining, L.C. and Stuttard, C. (eds.). Butterworth-Heinemann, Boston.
Summers, R.G., Donadio, S., Staver, M., Wendt-Pienkowski, E., Hutchinson, C. R. and Katz, L. 1997. Characterization of ten genes from the erythromycin gene cluster of Saccharopolyspora erythraea that are involved in L-mycarose and D-desosamine biosynthesis. Microbiology 143: 3251–3262.
Occi, J.L., Gerwain, K.M., Ruby, C.L., and MacNeil, D.J. 1991. Abstracts of the annual meeting of the society for industrial microbiology, P49. p. 93. Philadelphia, PA.
Jiang, X.-M., Neal, B., Santiago, F., Lee, S.J., Romana, L.K., and Reeves, P.R. 1991. Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol.. Microbiol. 5: 695–713.
Macpherson, D.F., Manning, P.A. and Morona, R. 1994. Characterization of the dTDP-rhamnose biosynthetic genes encoded in the rfb locus of Shigella flexneri. Mol. Microbiol. 11: 281–292.
Vara, J., Lewandowska-Skarbek, M., Wang, Y.-G., Donadio, S. and Hutchinson, C.R. 1989. Cloning of genes governing the deoxysugar portion of the erythromycin biosynthetic pathway in Saccharopolyspora erythraea (Streptomyces erythreus). J. Bacteriol. 171: 5872–5881.
Bibb, M.J., White, J., Ward, J.M., and Janssen, G.R. 1994. The mRNA for the 23S rRNA methylase encoded by the ermE gene of Saccharopolyspora erythraea is translated in the absence of a conventional ribosome-binding site. Mol. Microbiol. 14: 533–545.
Tagliavini, F., McArthur, R.A., Canciani, B., Giaccone, G., Porro, M., Bugiani, M., et al. 1997. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276: 1119–1122.
Dingerdissen, J.J., Sitrin, R.D., DePhillips, P.A., Gionenella, A.J., Grappel, S.F., Mehta, R.J., et al. 1987. Actinoidin A2, a novel glycopeptide: Production, preparative HPLC separation and characterization. J. Antibiotics 40: 165–172.
Lomovskaya, N., Filippini, S., Fonstein, L., Hutchinson, C.R. and Colombo, A.L. 1997. Process for preparing doxorubicin. US patent applied for.
Inventi-Scolari, A., Breme, U., Colombo, A.L., Hutchinson, C.R., Otten, S., and Scotti, C. 1996. Process for preparing doxorubicin. WO 96/27014, Sept. 6,1996.
Kurihara, K., Ajito, K., Shibahara, S., Ishizuka, T., Hara, O., Araake, M., and Omoto, S. 1996. Cladinose analogoues of sixteen-membered macrolide antibiotics. I. Synthesis of 4-O-alkyl-L-cladinose analogues via glycosylation. J. Antibiotics 49: 582–592.
Solenberg, P.J., Matsushima, P., Stack, D.R., Wilkie, S.C., Thompson, R.C., and Baltz, R.H. 1997. Production of hybrid glycopeptide antibiotics in vitro and in Streptomyces toyocaensis. Chem. Biol. 4: 195–202.
Yanisch-Perron, C., Vieira, J., and Messing, J. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33: 103–119.
Sambrook, J., Frisch, E.F. and Maniatis, T. 1989. Molecular cloning. A laboratory manual, Vols. 1 to 3. Cold Spring Harbor Press, Cold Spring Harbor, New York.
Hopwood, D.A., Bibb, M.J., Chater, K.F., Kieser, T., Bruton, C.J., Kieser, H.M., et al. 1985. Genetic manipulation of Streptomyces: A laboratory manual. The John Innes Foundation, Norwich, UK.
Guilfoile, P.G. and Hutchinson, C.R. 1991. A bacterial analog of the mdr gene of mammalian tumor cells is present in Streptomyces peucetius, the producer of daunorubicin and doxorubicin. Proc. Natl. Acad. Sci. USA 88: 8553–8557.
Meurer, G. and Hutchinson, C.R. 1995. Functional analysis of putative β-ketoa-cyl:acyl carrier protein synthase and acyltransferase active-site-motifs in a type II polyketide synthase of Streptomyces glaucescens. J. Bacteriol. 177: 477–481.
Hillemann, D., Puhler, A., and Wohlleben, W. 1991. Gene disruption and gene replacement in Streptomyces via single stranded DNA transformation of integration vectors. Nucl. Acids Res. 19: 727–731.
Strohl, W.R. 1992. Compilation and analysis of DNA sequences associated with apparent streptomycetes promoters. Nucl. Acids Res. 20: 961–974.
Devereux, J., Haeberli, P., and Smithies, O. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucl. Acids Res. 12: 387–395.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Madduri, K., Kennedy, J., Rivola, G. et al. Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius. Nat Biotechnol 16, 69–74 (1998). https://doi.org/10.1038/nbt0198-69
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0198-69
This article is cited by
-
The snogI Gene is Necessary for the Proper Functioning of the Nogalamycin Biosynthesis Pathway
Indian Journal of Microbiology (2021)
-
Elucidation of the glycosylation steps during biosynthesis of antitumor macrolides PM100117 and PM100118 and engineering for novel derivatives
Microbial Cell Factories (2016)
-
Bioconversion of deoxysugar moieties to the biosynthetic intermediates of daunorubicin in an engineered strain of Streptomyces coeruleobidus
Biotechnology Letters (2014)
-
Perspectives in Metabolic Engineering: Understanding Cellular Regulation Towards the Control of Metabolic Routes
Applied Biochemistry and Biotechnology (2013)
-
Validation of high-performance liqid chromatography method to determine epirubicin and its pharmacokinetics after intravenous bolus administration in rats
Journal of Pharmaceutical Investigation (2013)